Hypogonadism

Latest News

Short-Acting Testosterone Replacement Therapy Better for Spermatogenesis

By

Endocrinology Advisor Contributing Writer

Study authors hypothesized that longer-acting testosterone replacement therapy will have significant impact on suppressing HPG axis compared with short-acting TRT preparations.

Treatment With Testosterone Significantly Reduces T2D Risk

By

Brandon May

Overweight or obese men frequently have low serum testosterone concentrations, which is associated with increased risk of type 2 diabetes.

Nasal Gel Increases Testosterone, Maintains Semen Parameters

By

Jody A. Charnow

In a study, most symptomatic hypogonadal men treated with Natesto, a short-acting 4.5% nasal testosterone gel, attained normal testosterone levels at 6 months while preserving sperm counts.

First Testosterone Undecanoate Softgel Approved by FDA for Hypogonadism

By

Steve Duffy

Jatenzo® (testosterone undecanoate; Clarus Therapeutics), an oral testosterone replacement therapy, is now available for the treatment of hypogonadism.

ACP Issues Guidelines for Use of Testosterone Therapy in Age-Related Low Testosterone

By

Rachael Beairsto

The American College of Physicians has issued a set of recommendations to clarify the potential benefits and harms of testosterone therapy in men with age-related low testosterone.

Waist Circumference Affects Coronary Plaque Accumulation in Testosterone Therapy

By

Amit Akirov, MD

Older men receiving testosterone treatment with higher waist-to-hip ratio experience greater increases in noncalcified coronary plaque volume.

Short-Term Testosterone Therapy Associated With VTE Risk in Men

For men with and without hypogonadism, testosterone therapy is associated with an increased short-term risk for venous thromboembolism.

Suboptimal Screening for Hypogonadism in Men Receiving Opioids

More men with long-term opioid use are screened for low testosterone than men taking opioids for a short period of time; however, given the known link between opioid use and low testosterone, these rates were still lower than expected.

Managing Opioid-Induced Androgen Deficiency

By

Endocrinology Advisor Contributing Writer

The increased opioid use has been associated with a rising incidence of opioid-induced endocrinopathy, most commonly in the form of androgen deficiency.

Testosterone Undecanoate May Reduce CV Morbidity, Mortality in Men With Hypogonadism, Type 2 Diabetes

By

Amit Akirov, MD

Long-term treatment with testosterone undecanoate was associated with reduced cardiovascular morbidity and mortality in patients with hypogonadism and type 2 diabetes.

Genetically Determined Low Vitamin D Concentrations Associated With Low Testosterone Levels

By

Amit Akirov, MD

Genetically low 25-hydroxyvitamin D levels are associated with lower testosterone levels.